Effect of iron deficiency and desferrioxamine on DNA synthesis in human cells.
Desferrioxamine (10(-3) M) caused a fall in the deoxyadenosine triphosphate level after 4 h incubation in normal phytohaemagglutinin-stimulated lymphocytes. There was a rise in the concentrations of the other three deoxyribonucleoside triphosphates (deoxythymidine-,deoxycytidine-and deoxyguanosine-triphosphate). The changes are similar to those caused by hydroxyurea, a known inhibitor of ribonucleotide reductase. Desferrioxamine (10(-3 M) was found to inhibit human lymphocyte ribonucleotide reductase to a mean of 11% of control activity after 45 min incubation. Both drugs, desferrioxamine and hydroxyurea, inhibited incorporation of [3H]thymidine DNA into lymphocytes in the presence or absence of deoxyuridine, and inhibited production of lymphocytic thymidine kinase, having opposite effects to methotrexate on both [3H]thymidine incorporation and thymidine kinase activity. Phytohaemagglutinin-stimulated lymphocytes from patients with chronic iron deficiency showed lower levels of all our deoxyribonucleoside triphosphates than normal lymphocytes. It is suggested that this may be due to reduced ribnucleotide reductase activity of the iron-deficient cells.
D000747:Anemia, Hypochromic / Q000097:blood*; D004247:DNA / Q000096:biosynthesis*; D003676:Deferoxamine / Q000494:pharmacology*; D003853:Deoxyribonucleosides / Q000096:biosynthesis / Q000097:blood; D005260:Female; D006801:Humans; D006918:Hydroxyurea / Q000494:pharmacology; D008213:Lymphocyte Activation; D008214:Lymphocytes / Q000032:analysis; D008297:Male; D012264:Ribonucleotide Reductases / Q000096:biosynthesis; D013936:Thymidine / Q000378:metabolism; D013937:Thymidine Kinase / Q000096:biosynthesis; D013997:Time Factors
D003853:Deoxyribonucleosides; D004247:DNA; D012264:Ribonucleotide Reductases; D013937:Thymidine Kinase; D003676:Deferoxamine; D013936:Thymidine; D006918:Hydroxyurea